GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Diamond Biofund Inc (TPE:6901) » Definitions » ROE % Adjusted to Book Value

Diamond Biofund (TPE:6901) ROE % Adjusted to Book Value : -10.63% (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Diamond Biofund ROE % Adjusted to Book Value?

Diamond Biofund's ROE % for the quarter that ended in Dec. 2024 was -28.49%. Diamond Biofund's PB Ratio for the quarter that ended in Dec. 2024 was 2.68. Diamond Biofund's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -10.63%.


Diamond Biofund ROE % Adjusted to Book Value Historical Data

The historical data trend for Diamond Biofund's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diamond Biofund ROE % Adjusted to Book Value Chart

Diamond Biofund Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial - - 1.68 -6.71 -8.09

Diamond Biofund Quarterly Data
Dec19 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.86 -8.75 -1.40 -9.11 -10.63

Competitive Comparison of Diamond Biofund's ROE % Adjusted to Book Value

For the Asset Management subindustry, Diamond Biofund's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diamond Biofund's ROE % Adjusted to Book Value Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Diamond Biofund's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Diamond Biofund's ROE % Adjusted to Book Value falls into.


;
;

Diamond Biofund ROE % Adjusted to Book Value Calculation

Diamond Biofund's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-21.67% / 2.68
=-8.09%

Diamond Biofund's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-28.49% / 2.68
=-10.63%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Diamond Biofund ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Diamond Biofund's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Diamond Biofund Business Description

Traded in Other Exchanges
N/A
Address
No. 236, Section 4, Xinyi Road,, 11th Floor, Daan District, Taipei City, TWN, 106047
Diamond Biofund Inc is a sustainable biotech venture capital that focuses on the field of biotechnology and medical investment, targeting global and internationally competitive investment targets, including new drug research and development, high-end medical equipment, innovative medical service technology, medical access, agricultural biotechnology.

Diamond Biofund Headlines

No Headlines